News

Doctor Evidence to Deploy Its AI-Enabled SaaS DOC Search™ and DOC Analytics™ Platform for COVID-19 to Accelerate Drug Discovery

Posted on

SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence (“DRE”) has developed new tools for automated network meta-analysis, to now be used in the hunt for the most effective treatments for COVID-19. Clinical trial data is continuously emerging that can now be aggregated in real time using DRE’s DOC Analytics™ platform. Read more…

News

DRE’s DOC Analytics™ Generates First-Ever Automated Network Meta-Analysis with Natural Language Question AI-Powered Search Results

Posted on

SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence (DRE) has updated their newly launched DOC Analytics™ (“Digital Outcome Conversion”) platform with industry standard network meta-analysis (NMA) capabilities. DOC Analytics™ provides immediate quantitative insights into the universe of medical information using artificial intelligence/machine learning (AI/ML) and natural language processing (NLP). With the addition of indirect treatment comparison and landscape analysis using NMA, DOC Analytics™ is a […]

News

Dr Evidence (DRE), an AI-Enabled SaaS Healthcare Insights Company, Taps Industry Experts Joseph A. Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its Newly Formed Medical Strategy Advisory Board

Posted on

SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE is pleased to welcome Joe Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its newly formed Medical Strategy Advisory Board (MSAB). These enhancements to the Company reflect the expanded need for keen guidance in this unprecedented time of convergence between expert AI-enabled technology in healthcare and […]

News

Doctor Evidence’s newly released DOC Analytics™ performs rapid network meta-analyses to generate real-time insights using natural language processing and rigorous methodology

Posted on

SANTA MONICA, Calif., May 19, 2020 /PRNewswire/ — Doctor Evidence (DRE), a leading Artificial Intelligence-powered SaaS healthcare insights company, has launched its revolutionary DOC (“Digital Outcome Conversion”) Analytics™ platform. DOC Analytics™ is a culmination of over 10-years of R&D and product development.  In DOC Analytics™, users can ask natural language medical questions and get precise search results that are powered by DRE’s DOC […]

News

Response to the Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset made available to Academic Researchers

Posted on

SANTA MONICA, Calif., March 17, 2020 /PRNewswire/ — Doctor Evidence (“DRE”) is focusing its AI-enabled  medical search engine on the COVID-19 medical literature and daily emerging breaking research. Today, as requested by The White House Office of Science and Technology Policy and in response to researchers call for AI machine-readable technology to address the fast evolving Coronavirus literature, […]

News

Doctor Evidence is Empowering Researchers with an Intuitive AI Solution for Rapid Literature Review and Surveillance – Updates to a User-Friendly Interface in DOC Search

Posted on

SANTA MONICA, Calif., June 19, 2019 /PRNewswire/ — Doctor Evidence, a global health technology and consulting company in biomedical research, releases new updates and an interactive user interface for the DOC Search platform on June 24th. DOC Search was designed to empower both novice and experienced researchers with a user-friendly turnkey solution to independently conduct rapid literature reviews and […]

News

DATA WITH LEADING AI SEARCH TECHNOLOGY

Posted on

Doctor Evidence and Pharmaspectra have formed an alliance where Pharmaspectra’s datahub, Insightmeme® global Congress data captured from monitoring over 18,000 meetings per year will be offered in Doctor Evidence’s powerful search platform, DOC Search®. Read More

Uncategorized

Efficacy and Safety of Hylan G-F 20 Versus Intra-Articular Corticosteroids

Posted on

AUTHORS: Chevalier X., Sheehan B., Whittington C., Ho C., Ngai W., Campos G. CONFERENCE: 2019 ACR/ARP Annual Meeting DATE: November 8-13, 2019. Objective: To evaluate the clinical efficacy and safety of Hylan G-F 20 in comparison with intra-articular corticosteroids in patients with knee OA, using both direct (pairwise) meta-analysis (MA) and network meta-analysis (NMA). See poster

News

Doctor Evidence is Training AI-Based Technology to Distinguish Real-World Evidence in Literature Search and Monitoring

Posted on

SANTA MONICA, Calif., June 3, 2019 /PRNewswire/ — Doctor Evidence (DRE), a global health technology and healthcare research consulting company, continues to breakthrough artificial intelligence (AI) hurdles with the ability to auto-identify research studies that are based on real-world evidence (RWE). Yesterday, at the AcademyHealth Annual Research Meeting in Washington DC, DRE presented a poster entitled, […]